1. J. Holoshitz, A. Matitiau and I. R. Cohen,Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J. Clin. Invest.73, 211–215 (1984).
2. M. E. J. Billingham,Models of arthritis and the search for anti-arthritic drugs. Pharmacol. Ther.21, 389–428 (1983).
3. P. Theisen-Popp, H. Pape and R. Müller-Peddinghaus,Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation. Int. J. Immunopharmacol.14, 565–571 (1992).
4. M. J. Dimartino, J. C. Lee, A. M. Badger, K. A. Muirhead, C. K. Mirabelli and N. Hanna, Antiarthritic and immunoregulatory activity of spirogermanium. J. Pharmacol. Exp. Ther.236, 103–110 (1986).
5. K. R. Gans, W. Galbraith, R. J. Roman, S. B. Haber, J. S. Kerr, W. K. Schmidt, C. Smith, W. E. Hewes and N. R. Ackerman, Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J. Pharmacol. Exp. Ther.254, 180–187 (1990).